Levetiracetam Prophylaxis in Brain Tumor Resection Pilot
Trial statusNot yet recruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorHamilton Health Sciences Corporation
About this trial
This study aims to evaluate feasibility of a double-blind randomized controlled trial for levetiracetam prophylaxis for prevention of seizure in the perioperative phase of brain tumor resection.
Eligibility criteria
Qualifiers
Adult age 18 years or older
Undergoing craniotomy for a brain tumor
Intra-axial tumor location
Supratentorial tumor location
Disqualifiers
Documented seizure history or epilepsy diagnosis
Currently taking an antiepileptic medication
Unable to take levetiracetam (e.g. allergy, inability to swallow)
Inability to obtain consent from participant or substitute decision maker prior to surgery
Trial design
Treatments tested in this trial
- Levetiracetam
- Placebo
Treatment groups
70 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Hamilton Health Sciences Corporation
Lead sponsor
McMaster University
Collaborator
Source ClinicalTrials.gov